Table 2 Estimated utilization of HCC surveillance
From: Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Condition | Burden in population | Estimated surveillance utilization |
|---|---|---|
With cirrhosis | 112 million individuals globally188 | <25%21 |
Chronic hepatitis B without cirrhosis | >250 million individuals globally189 | ~33%37 |
NAFLD | 1 in 3 adults49 affected globally – low incidence of HCC but large at-risk population | Unknown |
HCC | >900,000 per year3 | ~25% received surveillance before HCC diagnosis21 |
